Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs SeaStar Medical Holding Corporation (ICU)

BioLineRx Ltd. and SeaStar Medical Holding Corporation are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $8.8M — 1.2× the size. SeaStar Medical Holding Corporation grew revenue faster over the last twelve months: 123.6% against −91.9%. BioLineRx Ltd. has the higher net margin (−502.1% vs −795.5%) and the lower return on invested capital (−74.3% vs 0.00%). Across the 17 metrics below, BioLineRx Ltd. leads on 9 and SeaStar Medical Holding Corporation on 8.

Valuation

Metric BLRX ICU Biotechnology median
P/E n/m n/m 10.26
P/S 5.65 4.53 9.18
P/B 0.47 1.81 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.06 1.96 8.98
Earnings yield (90.47%) (205.79%) (34.89%)
Free cash flow yield (137.86%) (176.47%) (24.52%)

Profitability

Metric BLRX ICU Biotechnology median
Gross margin 80.03% 92.64% 65.16%
Operating margin (874.28%) (816.75%) 0.00%
Net margin (502.08%) (795.50%) 0.00%
Free cash flow margin (776.29%) (799.36%) 0.00%
Return on equity (38.10%) (356.87%) (50.12%)
Return on assets (18.21%) (160.02%) (45.60%)
Return on invested capital (74.28%) 0.00% 0.00%

Growth

Metric BLRX ICU Biotechnology median
Revenue growth (TTM) (91.93%) 123.63% 6.26%
EPS growth (last fiscal year) 93.72% 91.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX ICU Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 1.89 4.89
Net debt to EBITDA 1.22 0.99 1.01

Dividend

Metric BLRX ICU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLRX ICU Biotechnology median
Market cap 8.80m 10.20m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack